The recent Visual Snow Syndrome (VSS) Masterclass, held in London, UK, offered an in-depth educational experience focused on diagnosing and managing Visual Snow Syndrome. Led by experts Dr. Charles Shidlofsky and Dr. Terry Tsang, the masterclass brought together 26 physicians and specialists from six different countries, including the United States, England, the Netherlands, Norway, Belgium, and Malaysia, reflecting the growing global interest in evidence-based VSS care.
The masterclass took place on November 15–16, 2025, at the Hilton London Heathrow Airport (Terminal 4) as part of the Neuro-Optometric Rehabilitation Association’s Clinical Skills 1 (CS1) program, which was hosted in the UK for the first time by the British Association of Behavioural Optometrists. The Visual Snow course was offered as an optional add-on to CS1 and provided participants with focused, hands-on education on the complexities of VSS. This comprehensive training equipped clinicians to apply Neuro-Optometric Rehabilitation Therapy (NORT) as a treatment approach for VSS patients, drawing directly from current clinical research and practice.
Dr. Shidlofsky, Dr. Tsang, and Vanessa Mora collaborated to develop the NORT protocol designed to address Visual Snow symptoms, with their research published under the title “The efficacy of neuro-optometric visual rehabilitation therapy in patients with visual snow syndrome” in peer-reviewed journals including Frontiers of Neurology and PubMed. Physicians and specialists who completed the VSS Masterclass were added to the Visual Snow Initiative’s Doctor Directory, allowing patients to directly access their contact information and book appointments with trained providers in their region.
This masterclass was made possible through the efforts of the Visual Snow Initiative, whose mission is to increase awareness of VSS, educate healthcare professionals worldwide, and make informed, evidence-based care more accessible to patients globally. VSI’s work ensures that doctors are better equipped to recognize and treat VSS, improving treatment options and overall patient outcomes.
Building on the success of the London program, additional international locations and virtual formats will be potentially explored to expand accessibility for healthcare professionals worldwide.
